The Godavari Biorefineries Limited IPO is poised to attract significant attention from investors. It opens for subscription on October 23, 2024, and closes on October 25, 2024. This public offering has garnered significant interest due to the company's unique positioning in the bio-based chemicals market. The IPO is set to raise approximately ₹554.75 crores, with the funds being used to repay outstanding borrowings and for general corporate purposes.
Godavari Biorefineries Limited is offering a combination of fresh shares and an offer for sale. The total issue size comprises 1.58 crore shares, aggregating to ₹554.75 crores. Out of this, a fresh issue of ₹325 crores will be raised through the sale of 0.92 crore shares, while the remaining ₹229.75 crores will be raised through the offer for the sale of 0.65 crore shares. The Godavari Biorefineries Limited IPO price band is set between ₹334 and ₹352 per share, with a minimum lot size of 42 shares.
The Godavari Biorefineries Limited IPO is one of the most anticipated upcoming IPOs. Below is the table summarizing the IPO details:
Particulars | Details |
Godavari Biorefineries Limited IPO opening date | October 23, 2024 |
Godavari Biorefineries Limited IPO closing date | October 25, 2024 |
Godavari Biorefineries Limited IPO price band | ₹334 to ₹352 per share |
Lot size | 42 shares |
Total issue size | ₹554.75 crores |
Fresh issue | ₹325 crores |
Offer for sale | ₹229.75 crores |
Listing at | BSE, NSE |
Face value | ₹10 per share |
Shareholding pre-issue | 41,943,023 |
Shareholding post-issue | 51,175,978 |
Below is the tentative schedule for the IPO:
Event | Date |
Godavari Biorefineries Limited IPO open date | October 23, 2024 |
Godavari Biorefineries Limited IPO close date | October 25, 2024 |
Cut-off time for UPI mandate confirmation | 5 PM on October 25, 2024 |
Basis of shares allotment | October 28, 2024 |
Initiation of refunds | October 29, 2024 |
Credit of shares to demat account | October 29, 2024 |
Godavari Biorefineries Limited IPO listing date | October 30, 2024 |
Incorporated in 1956, Godavari Biorefineries Limited is one of India's leading manufacturers of ethanol-based chemicals. The company operates an integrated biorefinery, which is the largest in the world in terms of capacity for producing Multi-Product Output (MPO). Godavari Biorefineries is the only Indian company to manufacture bio-ethyl acetate and natural 1,3-butanediol, demonstrating its technological edge in the market.
The company has two manufacturing facilities in Karnataka and Maharashtra. It serves clients in various sectors, such as food and beverages, pharmaceuticals, personal care, and industrial chemicals. It has a well-established customer base in over 20 countries, making it a significant player in the global biochemicals market.
Godavari Biorefineries has faced some financial setbacks over the past few years due to changes in government policies and natural calamities. The revenue for the year ending March 31, 2024, decreased by 15.92%, while the profit after tax dropped by 37.37% compared to the previous year. However, with the liberalisation of ethanol production norms, the company is poised for a turnaround, backed by improved industry conditions and a focus on high-value bio-based products.
Period ended | 30 Jun 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
Assets | ₹1,554.62 Cr | ₹1,991.66 Cr | ₹1,743.52 Cr | ₹1,733.54 Cr |
Revenue | ₹525.27 Cr | ₹1,701.06 Cr | ₹2,023.08 Cr | ₹1,709.98 Cr |
Profit after tax | -₹26.11 Cr | ₹12.30 Cr | ₹19.64 Cr | ₹19.10 Cr |
Net worth | ₹233.84 Cr | ₹260.25 Cr | ₹249.01 Cr | ₹232.57 Cr |
Total Borrowings | ₹703.75 Cr | ₹663.27 Cr | ₹738.01 Cr | ₹636.72 Cr |
Reserve and surplus | ₹432.34 Cr | ₹458.74 Cr | ₹447.51 Cr | ₹431.06 Cr |
The Godavari Biorefineries Limited IPO review emphasises several strengths that make this IPO appealing to investors:
Despite its strengths, the Godavari Biorefineries Limited IPO presents certain challenges for potential investors:
The decision to invest in the Godavari Biorefineries Limited IPO depends on your risk appetite and investment goals. The IPO may appeal to long-term investors who are willing to take a calculated risk on the company's future growth potential. The liberalisation of ethanol production policies and a shift towards renewable chemicals present significant growth opportunities.
However, it is important to consider the recent financial performance and the company's high debt levels. As part of your IPO investment strategy, it may be wise to evaluate the company's growth plans and the potential impact of industry-specific risks. Reviewing the Godavari Biorefineries Limited IPO GMP (grey market premium) closer to the listing date can also offer insights into market sentiment.
The company has experienced fluctuating revenues and profits over the past three years, with notable revenue growth in FY2024 but also facing challenges with profitability.
The company is one of the largest integrated sugar and ethanol manufacturers in India, benefiting from government support for ethanol blending programs and a diversified product portfolio.
The company faces risks such as fluctuating raw material prices, regulatory changes, and the impact of weather on sugarcane production, which could affect its performance.
Yes, the IPO includes an offer for sale portion, where existing shareholders will sell shares worth ₹229.75 crores.